Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Depreciation and Depletion (2016 - 2024)

Perspective Therapeutics' Depreciation and Depletion history spans 11 years, with the latest figure at -$1.6 million for Q4 2024.

  • On a quarterly basis, Depreciation and Depletion fell 250.66% to -$1.6 million in Q4 2024 year-over-year; TTM through Sep 2025 was -$1.6 million, a 239.89% decrease, with the full-year FY2023 number at $232000.0, down 13.11% from a year prior.
  • Depreciation and Depletion hit -$1.6 million in Q4 2024 for Perspective Therapeutics, down from $669000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for CATX hit a ceiling of $669000.0 in Q3 2024 and a floor of -$1.6 million in Q4 2024.
  • Historically, Depreciation and Depletion has averaged $41526.3 across 5 years, with a median of $64000.0 in 2022.
  • The widest YoY moves for Depreciation and Depletion: up 280.88% in 2023, down 427.54% in 2023.
  • Tracing CATX's Depreciation and Depletion over 5 years: stood at $37000.0 in 2020, then crashed by 310.81% to -$78000.0 in 2021, then surged by 276.92% to $138000.0 in 2022, then tumbled by 427.54% to -$452000.0 in 2023, then plummeted by 250.66% to -$1.6 million in 2024.
  • Business Quant data shows Depreciation and Depletion for CATX at -$1.6 million in Q4 2024, $669000.0 in Q3 2024, and $570000.0 in Q2 2024.